Cargando…
Intravitreal bevacizumab for macular edema due to proton beam radiotherapy: Favorable results shown after eighteen months follow-up
PURPOSE: To evaluate the safety and efficacy of intravitreal injections of bevacizumab (Avastin(®)) as a treatment option for radiation maculopathy secondary to proton beam radiotherapy for choroidal melanoma. CASE: A 61-year-old woman presented with a gradual decrease in left eye visual acuity (VA)...
Autores principales: | Loukianou, Eleni, Brouzas, Dimitrios, Georgopoulou, Eleni, Koutsandrea, Chrysanthi, Apostolopoulos, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878959/ https://www.ncbi.nlm.nih.gov/pubmed/20526443 |
Ejemplares similares
-
Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin(®)) for AMD followed by controlateral sympathetic ophthalmia
por: Brouzas, Dimitrios, et al.
Publicado: (2009) -
Keratoconjunctivitis and Periorbital Edema due to Ecballium elaterium
por: Brouzas, Dimitrios, et al.
Publicado: (2012) -
Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009) -
Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012) -
Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)